{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:58:22Z","timestamp":1776898702626,"version":"3.51.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Prostate squamous cell carcinoma (SCCP)is a rare malignancy that accounts for 1% of prostate cancer cases. In resource-limited settings, it is often at an advanced stage due to the limitations of PSA\/imaging-based methods, and pathological confirmation is needed for a definitive diagnosis, particularly in elderly patients with comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>A 71-year-old male with benign prostatic hyperplasia presented with urinary obstruction confirmed by urine flowmetry. Digital rectal examination of the prostate revealed severe enlargement, a firm consistency and an irregular surface; B-mode ultrasonography revealed calcifications without focal lesions. Laboratory tests revealed hematuria, elevated RBC counts, reduced WBC counts, normal serum PSA, and negative microbiological cultures. Cystoscopy revealed bladder wall thickening with multiple diverticula, suggesting chronic obstructive sequelae. Through physical, laboratory, and imaging examinations, we diagnosed the patient with benign prostatic hyperplasia before surgery. The postoperative pathological diagnosis was SCCP. The patient was discharged 7 days post-surgery and treated for prostate cancer (PCa) at a higher-level hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:italic>in vivo<\/jats:italic> fluorescence imaging and laboratory examination of PCa targets are needed to further promote noninvasive PCa diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2025.1532669","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T05:24:56Z","timestamp":1752729896000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Challenges in the diagnosis of primary squamous cell carcinoma of the prostate: a case report and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Shengyou","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/JU.0000000000002993","article-title":"Prostate specific antigen testing behaviors for prostate cancer screening among U.S. Immigrants: a cross-sectional analysis using the national health interview survey","volume":"209","author":"Hansen","year":"2023","journal-title":"J Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S2589-7500(20)30314-9","article-title":"Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the surveillance, epidemiology, and End results (SEER) database","volume":"3","author":"Lee","year":"2021","journal-title":"Lancet Digit Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0022-5347(17)55966-2","article-title":"Mucinous adenocarcinoma probably arising in the renal pelvis and ureter: a case report","volume":"123","author":"Brawer","year":"1980","journal-title":"J Urol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.1016\/j.clgc.2020.02.002","article-title":"Outcomes for young men with localized intermediate-risk prostate cancer: an analysis of the NCDB","volume":"18","author":"Chua","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.eururo.2014.09.049","article-title":"Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level","volume":"67","author":"Karantanos","year":"2015","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/onc.2013.207","article-title":"Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model","volume":"32","author":"Henkels","year":"2013","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/pros.24304","article-title":"Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin","volume":"82","author":"Lindh","year":"2022","journal-title":"Prostate"},{"key":"B11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/dc.24415","article-title":"Bizarre benign cells in peri-rectal endoscopic ultrasound-guided fine-needle aspiration due to seminal vesicle sampling","volume":"48","author":"Satturwar","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/ncb2219","article-title":"Coordinated transcriptional regulation underlying the circadian clock in Arabidopsis","volume":"13","author":"Li","year":"2011","journal-title":"Nat Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41585-021-00545-2","article-title":"The placebo and nocebo effects in functional urology","volume":"19","author":"Mostafaei","year":"2022","journal-title":"Nat Rev Urol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/iju5.12365","article-title":"Successful treatment with DCF chemotherapy and radiotherapy for primary squamous cell carcinoma of the prostate","volume":"4","author":"Atagi","year":"2021","journal-title":"IJU Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.11604\/pamj.2019.34.125.19421","article-title":"Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment","volume":"34","author":"Ichaoui","year":"2019","journal-title":"Pan Afr Med J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/diagnostics14060645","article-title":"Primary adenosquamous carcinoma of the prostate","volume":"14","author":"Demianets","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1442-2042.2003.00580.x","article-title":"Squamous cell carcinoma of the prostate","volume":"10","author":"Mohan","year":"2003","journal-title":"Int J Urol"},{"key":"B19","first-page":"e6184","article-title":"Post-Brachytherapy transformation of prostatic adenocarcinoma to squamous cell carcinoma: a cadaver anatomy case report","volume":"11","author":"D'angelo","year":"2019","journal-title":"Cureus"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S0","DOI":"10.4103\/jcrt.jcrt_1039_21","article-title":"Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma","volume":"19","author":"Naik","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00018-017-2666-y","article-title":"A double dealing tale of p63: an oncogene or a tumor suppressor","volume":"75","author":"Chen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3892\/or.2021.7997","article-title":"HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63-mediated tight junction molecules and p21-mediated growth arrest","volume":"45","author":"Kakiuchi","year":"2021","journal-title":"Oncol Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"575317","DOI":"10.3389\/fonc.2020.575317","article-title":"Analysis of CK5\/6 and EGFR and its effect on prognosis of triple negative breast cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/cancers14020300","article-title":"Imaging immune cells using fc domain probes in mouse cancer xenograft models","volume":"14","author":"Bernhard","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1038\/s41598-024-55569-6","article-title":"Developing efficient strategies for localizing the enhanced yellow fluorescent protein subcellularly in transgenic eimeria parasites","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s00262-023-03472-w","article-title":"Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy","volume":"72","author":"Pachmayr","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/intimm\/dxaa037","article-title":"Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity","volume":"33","author":"Kobayashi","year":"2021","journal-title":"Int Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/pharmaceutics16050652","article-title":"Drug integrating amphiphilic nano-assemblies: 2. Spatiotemporal distribution within inflammation sites","volume":"16","author":"De Toni","year":"2024","journal-title":"Pharmaceutics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"113253","DOI":"10.1016\/j.jim.2022.113253","article-title":"Tracking fluorescently labeled IL-15 and anti-PD-1 in the tumor microenvironment and draining lymph nodes","volume":"505","author":"Reyes","year":"2022","journal-title":"J Immunol Methods"},{"key":"B31","first-page":"56","article-title":"Squamous cell carcinoma of the prostate","volume":"13","author":"Malik","year":"2011","journal-title":"Rev Urol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/curroncol31050178","article-title":"Mixed adenosquamous cell carcinoma of the prostate with paired sequencing on the primary and liver metastasis","volume":"31","author":"Oyogoa","year":"2024","journal-title":"Curr Oncol"},{"key":"B33","first-page":"243","article-title":"Synchronous development of prostate sarcoma and squamous cell carcinoma following radiotherapy","volume":"35","author":"Thota","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B34","first-page":"116","article-title":"Genome and transcriptome profiling of FBXW family in human prostate cancer","volume":"8","author":"Lan","year":"2020","journal-title":"Am J Clin Exp Urol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1038\/onc.2017.42","article-title":"\u0394np63\u03b1 promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82","volume":"36","author":"Di Giacomo","year":"2017","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.urology.2016.11.040","article-title":"Prostate-specific membrane antigen-targeted ligand positron emission tomography\/computed tomography and immunohistochemical findings in a patient with synchronous metastatic penile and prostate cancer","volume":"101","author":"Froehner","year":"2017","journal-title":"Urology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.18632\/oncotarget.1817","article-title":"Targeted inhibition of cell-surface serine protease hepsin blocks prostate cancer bone metastasis","volume":"5","author":"Tang","year":"2014","journal-title":"Oncotarget"},{"key":"B38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/00365599.2012.721393","article-title":"High-intensity focused ultrasound in prostate cancer: today\u2019s outcomes and tomorrow\u2019s perspectives","volume":"47","author":"Palermo","year":"2013","journal-title":"Scand J Urol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.juro.2008.09.024","article-title":"Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience","volume":"181","author":"Mearini","year":"2009","journal-title":"J Urol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ucl.2008.05.007","article-title":"Minimally invasive surgical approaches and management of prostate cancer","volume":"35","author":"Gonzalgo","year":"2008","journal-title":"Urol Clin North Am"},{"key":"B41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1586\/14737140.8.6.957","article-title":"Minimally invasive surgical modalities in the management of localized prostate cancer","volume":"8","author":"Jamal","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.canrad.2010.07.222","article-title":"Salvage treatments for prostatic radiation failure","volume":"14","author":"Baumert","year":"2010","journal-title":"Cancer Radiother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.suronc.2009.02.002","article-title":"Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer","volume":"18","author":"Ahmed","year":"2009","journal-title":"Surg Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/MOU.0b013e3282f20157","article-title":"Nonablative minimally invasive thermal therapies in the treatment of symptomatic benign prostatic hyperplasia","volume":"18","author":"D'ancona","year":"2008","journal-title":"Curr Opin Urol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.amsu.2020.05.029","article-title":"Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review","volume":"56","author":"Ziglioli","year":"2020","journal-title":"Ann Med Surg (Lond)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1442-2042.2011.02936.x","article-title":"High-intensity focused ultrasound therapy for prostate cancer","volume":"19","author":"Uchida","year":"2012","journal-title":"Int J Urol"},{"key":"B47","first-page":"1080","article-title":"Primary squamous cell carcinoma of the prostate: clinical features and therapeutic strategies","volume":"28","author":"Chen","year":"2022","journal-title":"Zhonghua Nan Ke Xue"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1532669\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T05:24:58Z","timestamp":1752729898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1532669\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":47,"alternative-id":["10.3389\/fsurg.2025.1532669"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1532669","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"article-number":"1532669"}}